terazosin

NDC 50090-7851 · A-S Medication Solutions

Generic nameterazosin

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TERAZOSIN HYDROCHLORIDE

Strength1 mg/1

Pharmacologic classAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]

Marketing categoryANDA

Packages

50090-7851-0 — 30 CAPSULE in 1 BOTTLE (50090-7851-0)

50090-7851-1 — 90 CAPSULE in 1 BOTTLE (50090-7851-1)

FDA lists these products with the same active ingredient.

27241-289 — Terazosin, 27241-290 — Terazosin, 27241-291 — Terazosin, 42291-820 — Terazosin Hydrochloride, 42291-821 — Terazosin Hydrochloride, 42291-822 — Terazosin Hydrochloride, 42291-823 — Terazosin Hydrochloride, 50090-0657 — Terazosin Hydrochloride, 50090-2371 — Terazosin Hydrochloride, 50090-2623 — Terazosin Hydrochloride, 50268-764 — Terazosin Hydrochloride, 50268-765 — Terazosin Hydrochloride, 50268-766 — Terazosin Hydrochloride, 50268-767 — Terazosin Hydrochloride, 51655-915 — terazosin, 53401-022 — terazosin, 59746-383 — Terazosin Hydrochloride, 59746-384 — Terazosin Hydrochloride, 59746-385 — Terazosin Hydrochloride, 59746-386 — Terazosin Hydrochloride, +62 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.